Author Guidelines

1. Submission

The document needs to be prepared in English language. The manuscript needs to be documented, maintaining double-spacing between lines along with a large margin. All the pages of the document need to be numbered in a sequence, including those containing figures, tabular columns, acknowledgements, references, etc. The documents containing the manuscript should be a single MS Word file. All figures and tables related to the manuscript need to be attached in the same word file. Submit your manuscript as an email attachment to submit@larixjournals.com


2.Terms of Submission

Submission of a manuscript to the Larix journals directly implies that all the authors have read and agreed to the journal's guidelines. The content present in the manuscript after publication will be freely available to all the potential readers over the Internet for noncommercial use. The content provided by the authors in the manuscript should at no point of time breach the copyrights or rights of third party. The manuscript submitted should not be published or submitted for consideration in any other journal.


3. Peer-Review Process

The journal follows double-blind peer-review process. This is done with the aim to minimize the possibility of a biased opinion when the reviewers know who the authors are and from where they come from, ensuring a responsible and ethical environment. Types of Articles:

Research Article

The submitted research article should contain no more than 4500–5000 words. There is no defined limit on the number of pages, images, and tabular columns.

Review Articles

The word count for a review article is 4000–5000 words, with no limitation on the number of pages, tables, and images being used.

Case Reports

The maximum word count for a case report is 1200–1600 words. Having no limit on the number of pages, figures, and references.

Clinical Images

While submitting clinical images, a maximum of 2 images needs to be used along with a word limit of 150 words.

Short Communications

A special issue publication is a group 10–15 articles on a specific theme, and a special issue article should contain a maximum of 4000–5000 words, with no limit on the number of references, pages, and images being used.

Editors-in-Chief


Editors

Dr . Dr. Sunitha Reddy M. Pharm., Ph.D., FPGEE, NABP(Mem), R.Ph. USA
Associate Professor
BOS Chairperson, CPS, IST, JNTU
India
Dr . Sandip Narayan Chakraborty Research Asst II
Translational Molecular Pathology
UT MD Anderson Cancer Center
USA
Prof . Prof. Dr. D. Satyavati M. Pharm., Ph.D
Department of Department of Pharmacology
Brilliant Group of Technical Institutions
India
Dr . Koteswara Rao Valasani
Pharmacy
Department of Pharmacology & Toxicology, University of Kansas
USA
Dr . Y. Ganesh Kumar M. Pharm., Ph.D
Associate Professor & HOD
Department of Pharmaceutics, Unity College of Pharmacy
India
Dr . R. Vijay Kumar M.Pharm., Ph.D
Team leader
APPCO Pharma, LLC, USA
India
Dr . Venkatesha Udupa
Senior General Manager
Toxicology, Glenmark Pharmaceuticals Limited
India
Dr . Kannappan Nagappan M. Pharm., Ph.D
Associate Professor
Annamalai University
India
Prof . R. Mannavalan M. Pharm., Ph.D
Prof
Annamalai University
India
Dr . Shaik Harun Rasheed M.Pharm., Ph.D., L.L.B, FAGE, A.I.C
Professor & Head
Department of Pharmaceutics, MRM College of Pharmacy
India
Dr . Sadanandam Palle
DST SERB Fast Track Young Scientist & Co-PI
JNT University
India
Dr . Ajitha M
Professor & OIE
Institute of Science and Technology, JNT-University
India

Reviewers